Compare BIO & DCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | DCI |
|---|---|---|
| Founded | 1952 | 1915 |
| Country | United States | United States |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Pollution Control Equipment |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 11.7B |
| IPO Year | N/A | 2005 |
| Metric | BIO | DCI |
|---|---|---|
| Price | $262.97 | $82.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $358.50 | $100.80 |
| AVG Volume (30 Days) | 235.7K | ★ 673.7K |
| Earning Date | 04-30-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 1.43% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.75 |
| Revenue | N/A | ★ $2,844,900,000.00 |
| Revenue This Year | $2.74 | $4.58 |
| Revenue Next Year | $3.05 | $5.08 |
| P/E Ratio | ★ $9.72 | $47.99 |
| Revenue Growth | N/A | ★ 4.05 |
| 52 Week Low | $211.43 | $57.45 |
| 52 Week High | $343.12 | $112.84 |
| Indicator | BIO | DCI |
|---|---|---|
| Relative Strength Index (RSI) | 40.24 | 21.12 |
| Support Level | $239.33 | $83.32 |
| Resistance Level | $289.61 | $94.26 |
| Average True Range (ATR) | 7.46 | 1.96 |
| MACD | 0.44 | -0.65 |
| Stochastic Oscillator | 19.99 | 12.01 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.7 billion in revenue in its fiscal 2025.